Abstract
Boron neutron capture therapy (BNCT) and magnetic resonance imaging (MRI) are quite attractive techniques for treatment and diagnosis of cancer, respectively. In order to develop practical materials utilizing both for BNCT and MRI, fluorinated p-boronophenylalanines and their alcohol derivatives had already been designed and synthesized. In the present paper the cytotoxicity, the incorporated amount into cancer cells, and the tumor cell killing effects of these compounds were elucidated to evaluate their usefulness as a boron carrier.
Keywords: Boron neutron capture therapy (BNCT), fluorinated p-boronophenylalanine, tumor cell killing effect, boron carrier
Protein & Peptide Letters
Title: Biological Evaluation of Fluorinated p-Boronophenylalanine Derivatives as a Boron Carrier
Volume: 14 Issue: 3
Author(s): Yoshihide Hattori, Kei Kurihara, Hirofumi Kondoh, Tomoyuki Asano, Mitsunori Kirihata, Yoshihiro Yamaguchi and Tateaki Wakamiya
Affiliation:
Keywords: Boron neutron capture therapy (BNCT), fluorinated p-boronophenylalanine, tumor cell killing effect, boron carrier
Abstract: Boron neutron capture therapy (BNCT) and magnetic resonance imaging (MRI) are quite attractive techniques for treatment and diagnosis of cancer, respectively. In order to develop practical materials utilizing both for BNCT and MRI, fluorinated p-boronophenylalanines and their alcohol derivatives had already been designed and synthesized. In the present paper the cytotoxicity, the incorporated amount into cancer cells, and the tumor cell killing effects of these compounds were elucidated to evaluate their usefulness as a boron carrier.
Export Options
About this article
Cite this article as:
Hattori Yoshihide, Kurihara Kei, Kondoh Hirofumi, Asano Tomoyuki, Kirihata Mitsunori, Yamaguchi Yoshihiro and Wakamiya Tateaki, Biological Evaluation of Fluorinated p-Boronophenylalanine Derivatives as a Boron Carrier, Protein & Peptide Letters 2007; 14 (3) . https://dx.doi.org/10.2174/092986607780090856
DOI https://dx.doi.org/10.2174/092986607780090856 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Microarray: An Approach for Current Drug Targets
Current Drug Metabolism A Role of Immunotherapy in Metastatic Malignant Melanoma
Central Nervous System Agents in Medicinal Chemistry Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Current Cancer Drug Targets Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
Recent Patents on Anti-Cancer Drug Discovery Temozolomide: An Update on Pharmacological Strategies to Increase its Antitumour Activity
Medicinal Chemistry Reviews - Online (Discontinued) Antibody Engineering, Virus Retargeting and Cellular Immunotherapy: One Ring to Rule Them All?
Current Gene Therapy Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
Current Medicinal Chemistry Protein Geranylgeranyltransferase Type 1 as a Target in Cancer
Current Cancer Drug Targets Signal Transduction in HIV Protein-Treated Astrocytes
Current Signal Transduction Therapy Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Mini-Reviews in Organic Chemistry The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors
Current Neuropharmacology Ectodomain Shedding and Regulated Intracellular Proteolysis in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Natural Proteinaceous Inhibitors of Serine Proteases
Current Pharmaceutical Design Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design The Role of Tumor-related LncRNA PART1 in Cancer
Current Pharmaceutical Design Cardiovascular Drug Development Using Radiopharmaceuticals
Current Pharmaceutical Design Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Integrins in Bone Metastasis Formation and Potential Therapeutic Implications
Current Cancer Drug Targets BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
Current Cancer Drug Targets